Bio-CR Oral Controlled-Release DDS

Bio-CR Oral Controlled-Release DDS
Product Description

NAL Pharmaceutical Group Limited offers captive DDS technology which includes Bio-CR oral controlled-release DDS. It is incorporated with captive API of proprietary manufacturing process and/or proprietary crystalline forms, coupled with non-infringing formulation/manufacturing process know-how, thereby allowing development of proprietary solid dosage forms and manufacturing processes within a relatively short development time period. It’s focused on developing low-solubility and super-saturation drug product. Contact us for more information.

NAL Pharmaceutical Group Limited

  • HK
  • 2017
    On CPHI since
Specifications
  • Selling Points
    Product Features; Prompt Delivery; Quality Service
  • Supplied from
    China

NAL Pharmaceutical Group Limited

  • HK
  • 2017
    On CPHI since

More Products from NAL Pharmaceutical Group Limited (2)

  • Bio-FX Sublingual Orally-Dissolving Film (ODF) DDS

    Product Bio-FX Sublingual Orally-Dissolving Film (ODF) DDS

    NAL Pharmaceutical Group Limited offers captive DDS technology which includes Bio-FX sublingual orally-dissolving film (ODF) DDS. It acts as an innovative dosage form principally for sublingual or oral cavity absorption, orally dissolving film (“ODF”) is formulated with a proprietary Bio-FX absorption enha...
  • Bio-D3 Transdermal Patch DDS

    Product Bio-D3 Transdermal Patch DDS

    NAL Pharmaceutical Group Limited offers captive DDS technology which includes Bio-D3 transdermal patch DDS.it is employed with proprietary Bio-D3 skin penetration enhancers to develop a wide range of patch delivery systems varying from localized action to transdermal absorption for up to 7 days. The new ge...